SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2023 financial results on Tuesday, November 7, 2023, after the close of the market.…Read More
Related Posts
BCC Research LLC COVID Taught the Public About RNAi Drug Delivery now the Market is…
BOSTON, Sept. 26, 2023 /PRNewswire/ -- Clinical trials utilizing RNAi drug delivery have surged, and BCC Research's new report "RNAi Drug Delivery: Technologies and Global Markets" predicts just how much…
Arvinas to Present at Stifel Targeted Oncology Day
NEW HAVEN, Conn., April 21, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced…
Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference Fortress Biotech NASDAQFBIO
MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. FBIO ("Fortress"), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product…
